the challenges in developing bispecific antibodies for non-hodgkin lymphoma
Published 2 years ago • 229 plays • Length 3:49Download video MP4
Download video MP3
Similar videos
-
2:25
advancements and challenges in bispecific antibodies for the treatment of b-nhl
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
2:56
the exciting future of bispecific antibodies
-
7:05
developments in the use of bispecific antibodies in myeloma and challenges in this space
-
1:45
challenges in mm guideline implementation
-
1:54
navigating regulatory challenges in developing and approving therapies for rare lymphomas
-
3:23
unanswered questions in aggressive b-cell lymphoma
-
1:48
the potential of bispecific antibody-containing combinations in patients with b-cell lymphomas
-
7:46
it's true, i have cancer. non-hodgkin lymphoma!
-
3:20
bispecific antibody
-
6:29
how are nk cells being used in anti-myeloma therapy?
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
1:14
are biomarkers the future in non-hodgkin lymphoma?
-
1:27
challenges in understanding the genomic landscape of hodgkin lymphoma
-
2:10
challenges in treating patients with hl who relapse after autosct & novel therapies being explored
-
10:40
evolving role of bispecific antibodies in b-cell non-hodgkin lymphomas (b-nhl)
-
18:00
evolving role of bispecific antibodies in b-cell non-hodgkin lymphomas (b-nhl)
-
1:02
the challenge of treating bpdcn in a resource-limited setting
-
0:43
the development of a composite comorbidity index to predict car-t outcomes in patients with dlbcl
-
1:17
integrating car-t in community-based practices across b-cell lymphomas: key challenges
-
1:24
the potential role of non-covalent btkis in mitigating covalent btki resistance
-
1:09
outpatient dosing of bispecific antibodies: what do clinicians need to consider?